GT Biopharma, Inc. — Director's Dealing 2003

Oct 24, 2003

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXIS INTERNATIONAL INC (OTTCBB)
CIK: 0000109657
Period of Report: 2003-10-24

Reporting Person: WEBB TED FORD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-09-30	Stock Option (right to buy)	$.38	A	30000	Disposed	2013-09-29	Common Stock (30000)	Direct